What is the prevalence of Pemphigoid?

TL;DR: Pemphigoid is a group of rare autoimmune blistering diseases with an estimated annual incidence of approximately 2 to 22 cases per million people, depending on the specific subtype and geographic region. While it is considered a rare disease, the prevalence of pemphigoid is rising due to an aging global population and improved clinical recognition of the condition.

What is the prevalence and incidence of pemphigoid?

Determining the exact prevalence of pemphigoid is challenging because it encompasses several distinct conditions, most notably Bullous Pemphigoid (BP), which is the most common form. According to Orphanet, the annual incidence of Bullous Pemphigoid is estimated at 2 to 22 per million individuals. Because pemphigoid is often underdiagnosed or misdiagnosed as other dermatological conditions, these numbers likely underestimate the true burden of the disease. In our DiseaseMaps.org community, 95 individuals have shared their experiences, highlighting that while pemphigoid is rare, it represents a significant and active community of patients seeking support and shared knowledge.

Who is most likely to develop pemphigoid?

The demographic profile of pemphigoid is heavily skewed toward older adults. Most clinical literature indicates that the average age of onset for bullous pemphigoid is between 70 and 80 years old. Pediatric cases are exceptionally rare and typically present with different clinical features. Regarding gender, data from the NIH GARD and other clinical registries suggest that there is no significant gender predisposition, though some studies have noted a slight variation in incidence rates depending on the specific autoimmune subtype. Ethnicity does not appear to be a primary driver of risk, although certain genetic predispositions may influence susceptibility in different populations.

Why is it difficult to track the true number of cases?

Accurate epidemiological data for pemphigoid is difficult to capture for several clinical reasons:

• Diagnostic Delay: Early symptoms often mimic common skin conditions like eczema or hives, leading to significant delays in accurate diagnosis.


• Clinical Heterogeneity: Because pemphigoid encompasses multiple subtypes—such as mucous membrane pemphigoid and bullous pemphigoid—data collection is often fragmented across different medical specialties.


• Lack of Centralized Registries: Many countries lack mandatory reporting for autoimmune blistering diseases, making it difficult for researchers to maintain precise, real-time prevalence statistics.


• Misclassification: Some patients are initially categorized under general "blistering disorders," obscuring the specific prevalence of pemphigoid.

Is pemphigoid considered a rare disease?

Yes, pemphigoid is classified as a rare disease by global health organizations. The rarity of the condition often leads to a "diagnostic odyssey" for patients, where they may consult multiple dermatologists and immunologists before receiving a definitive diagnosis. This is why platforms like DiseaseMaps.org are vital; by aggregating patient-reported data, we can better understand the real-world impact of the disease beyond the clinical statistics found in textbooks. While it is not "ultra-rare," the limited number of specialists familiar with the nuances of pemphigoid management makes it a condition that requires specialized, expert care.

Next steps

• Consult a board-certified dermatologist or an immunodermatologist who specializes in autoimmune blistering diseases.


• Request a direct immunofluorescence (DIF) biopsy, which is the gold standard for confirming a diagnosis of pemphigoid.


• Join the DiseaseMaps.org community to connect with the 95+ members who are navigating similar diagnostic and treatment journeys.


• Monitor for new clinical trials via clinicaltrials.gov to stay informed on emerging therapeutic options.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• Orphanet: Rare Disease Database (Bullous Pemphigoid).


• NIH Genetic and Rare Diseases Information Center (GARD).


• PubMed/NCBI: "Epidemiology of autoimmune blistering diseases" (Systematic Review).


• The International Pemphigus and Pemphigoid Foundation (IPPF).